CANTON, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Avitar, Inc. (OTC: AVRN)("Avitar" or the "Company") clarified today that the trading symbol on the pink sheets is "AVRN." Avitar common stock is now being quoted for trading on the pink sheets under the symbol "AVRN." This announcement corrects the information contained in the Press Release dated Thursday, August 25, 2005, which indicated that the symbol would be "AVR." About Avitar Avitar, Inc. develops, manufactures and markets innovative and proprietary products. Their field includes the oral fluid diagnostic market, the disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Avitar manufactures ORALscreen(R), the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse, as well as HYDRASORB(R), an absorbent topical dressing for moderate to heavy exudating wounds. Avitar is also developing diagnostic strategies for disease and clinical testing in the estimated $25 billion in-vitro diagnostics market. Conditions targeted include influenza, diabetes, and pregnancy. For more information, see Avitar's website at http://www.avitarinc.com/. Safe Harbor Statement. This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements. Company Contact: Jay C. Leatherman, CFO Avitar, Inc. Tel: 781-821-2440 http://www.avitarinc.com/ DATASOURCE: Avitar, Inc. CONTACT: Jay C. Leatherman, CFO of Avitar, Inc., +1-781-821-2440, Web site: http://www.avitarinc.com/

Copyright